SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $248 | +210.0% | 43,684 | +206.6% | 0.00% | +200.0% |
| Q4 2022 | $80 | -99.9% | 14,247 | -10.5% | 0.00% | 0.0% |
| Q3 2022 | $102,000 | +2.0% | 15,916 | +32.4% | 0.00% | 0.0% |
| Q4 2021 | $100,000 | -97.3% | 12,018 | -97.7% | 0.00% | -94.1% |
| Q3 2021 | $3,688,000 | +913.2% | 529,935 | +3372.7% | 0.02% | +750.0% |
| Q2 2021 | $364,000 | +4.9% | 15,260 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $347,000 | -25.1% | 16,859 | -10.7% | 0.00% | 0.0% |
| Q4 2020 | $463,000 | +245.5% | 18,885 | -33.0% | 0.00% | +100.0% |
| Q2 2020 | $134,000 | +294.1% | 28,188 | +167.9% | 0.00% | – |
| Q2 2019 | $34,000 | – | 10,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |